ghk-cu mechanism of action receptor Peptide: Mechanism, Anti-Aging Research, and Regenerative Benefits GHK-CU - Research Peptide -

References: Babu MM, Luscombe NM, Aravind L, Gerstein M, Teichmann SA

S., Poirier, G

intravenous (some studies) Protocol: Cyclic -- 5-10 mg/day for 10-20 consecutive days, repeated every 4-6 months (2-3 cycles per year) Rationale: Brief telomerase activation extends telomeres, which then provide sustained replicative capacity during drug-free intervals Requirements: Sterile reconstitution, cold chain storage, injection supplies, injection technique Regulatory status: FDA Category 2 since 2024 (banned from compounding in the US) NAD+# Route: Oral (NMN, NR supplements)

IV: Inject 500 mg as an IV push slowly over 3 to 5 minutes

The dipole moment of a molecule is a key factor in determining its solubility, especially in polar solvents